Sign in

CIK 0001651308

  • Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981209416
Phone
+41 616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$48,487,541
in 9 filings, $47.8M under 10b5-1 plans

Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2018-11-12 Peterson Amy C. CMO, Immuno-oncology Sale −100 $121.56 $12K 0
2018-11-12 Peterson Amy C. CMO, Immuno-oncology Exercise or conversion · Share Option (Right to Buy) −156,871 1,080,000
2018-11-09 Peterson Amy C. CMO, Immuno-oncology Exercise or conversion +13,222 $29.10 $385K 13,222
2018-11-09 Peterson Amy C. CMO, Immuno-oncology Sale −4,031 $118.64 $478K 9,191
2018-11-09 Peterson Amy C. CMO, Immuno-oncology Sale −1,725 $119.27 $206K 7,466
2018-11-09 Peterson Amy C. CMO, Immuno-oncology Sale −2,100 $120.63 $253K 5,366
2018-11-09 Peterson Amy C. CMO, Immuno-oncology Sale −2,898 $121.71 $353K 2,468
2018-11-09 Peterson Amy C. CMO, Immuno-oncology Sale −2,046 $122.55 $251K 422
2018-11-09 Peterson Amy C. CMO, Immuno-oncology Sale −322 $123.75 $40K 100
2018-11-09 Peterson Amy C. CMO, Immuno-oncology Sale −100 $125.97 $13K 0
2018-11-09 Peterson Amy C. CMO, Immuno-oncology Exercise or conversion · Share Option (Right to Buy) −171,886 1,236,871
2018-11-08 Peterson Amy C. CMO, Immuno-oncology Exercise or conversion +14,711 $29.10 $428K 14,711
2018-11-08 Peterson Amy C. CMO, Immuno-oncology Sale −466 $122.86 $57K 14,245
2018-11-08 Peterson Amy C. CMO, Immuno-oncology Sale −2,423 $124.48 $302K 11,822
2018-11-08 Peterson Amy C. CMO, Immuno-oncology Sale −3,949 $126.08 $498K 7,873
2018-11-08 Peterson Amy C. CMO, Immuno-oncology Sale −7,673 $126.72 $972K 200
2018-11-08 Peterson Amy C. CMO, Immuno-oncology Sale −200 $127.61 $26K 0
2018-11-08 Peterson Amy C. CMO, Immuno-oncology Exercise or conversion · Share Option (Right to Buy) −191,243 1,408,757
2018-09-04 Huang Jane CMO, Hematology Sale −2,911 $174.60 $508K 0
2018-08-30 Glazer Donald W. Director Sale −1,000 $179.00 $179K 13,384

Page 109 of 123 · 2,455 trades